SG11202005254RA - 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors - Google Patents
1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitorsInfo
- Publication number
- SG11202005254RA SG11202005254RA SG11202005254RA SG11202005254RA SG11202005254RA SG 11202005254R A SG11202005254R A SG 11202005254RA SG 11202005254R A SG11202005254R A SG 11202005254RA SG 11202005254R A SG11202005254R A SG 11202005254RA SG 11202005254R A SG11202005254R A SG 11202005254RA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibitors
- histone deacetylase
- oxadiazole derivatives
- oxadiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17382835 | 2017-12-05 | ||
EP18382562 | 2018-07-26 | ||
PCT/EP2018/083655 WO2019110663A1 (en) | 2017-12-05 | 2018-12-05 | 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202005254RA true SG11202005254RA (en) | 2020-07-29 |
Family
ID=64556931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202005254RA SG11202005254RA (en) | 2017-12-05 | 2018-12-05 | 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors |
Country Status (12)
Country | Link |
---|---|
US (2) | US20200339569A1 (he) |
EP (1) | EP3720851A1 (he) |
JP (1) | JP7369458B2 (he) |
KR (1) | KR20200097294A (he) |
CN (1) | CN111406054B (he) |
AU (1) | AU2018379321B2 (he) |
BR (1) | BR112020010534A2 (he) |
CA (1) | CA3083061A1 (he) |
IL (1) | IL274973B1 (he) |
MX (1) | MX2020005841A (he) |
SG (1) | SG11202005254RA (he) |
WO (1) | WO2019110663A1 (he) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
EP3980416A1 (en) * | 2019-06-06 | 2022-04-13 | Oryzon Genomics, S.A. | 3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors |
KR102576148B1 (ko) * | 2020-04-13 | 2023-09-07 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
KR20220030134A (ko) * | 2020-09-02 | 2022-03-10 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 새로운 구조의 화합물 및 이를 포함하는 약제학적 조성물 |
CN117561059A (zh) | 2021-04-23 | 2024-02-13 | 特纳亚治疗股份有限公司 | 用于治疗扩张型心肌病的hdac6抑制剂 |
IL308152A (he) | 2021-05-04 | 2024-01-01 | Tenaya Therapeutics Inc | 2-פלואורואלקיל-4,3,1-אוקסאדיאזול-5-איל-תיאזול, מעכבי hdac6 לשימוש בטיפול במחלה מטבולית ו hfpef |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2006109817A1 (ja) | 2005-04-06 | 2008-11-20 | 萬有製薬株式会社 | 1,4−置換ピペラジン誘導体 |
WO2013066839A2 (en) | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
AU2012345557A1 (en) * | 2011-11-28 | 2014-06-26 | Novartis Ag | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
EP3342772A4 (en) | 2015-08-25 | 2019-03-27 | Takeda Pharmaceutical Company Limited | HETEROCYCLIC COMPOUND |
WO2017161033A1 (en) | 2016-03-15 | 2017-09-21 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
WO2017222952A1 (en) | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
PL3558984T3 (pl) | 2016-12-20 | 2024-01-15 | Fmc Corporation | Oksadiazole grzybobójcze |
-
2018
- 2018-12-05 AU AU2018379321A patent/AU2018379321B2/en active Active
- 2018-12-05 SG SG11202005254RA patent/SG11202005254RA/en unknown
- 2018-12-05 WO PCT/EP2018/083655 patent/WO2019110663A1/en unknown
- 2018-12-05 MX MX2020005841A patent/MX2020005841A/es unknown
- 2018-12-05 JP JP2020550896A patent/JP7369458B2/ja active Active
- 2018-12-05 EP EP18811280.9A patent/EP3720851A1/en active Pending
- 2018-12-05 CA CA3083061A patent/CA3083061A1/en active Pending
- 2018-12-05 BR BR112020010534-1A patent/BR112020010534A2/pt unknown
- 2018-12-05 IL IL274973A patent/IL274973B1/he unknown
- 2018-12-05 CN CN201880077326.0A patent/CN111406054B/zh active Active
- 2018-12-05 KR KR1020207019402A patent/KR20200097294A/ko not_active Application Discontinuation
- 2018-12-05 US US16/768,931 patent/US20200339569A1/en not_active Abandoned
-
2022
- 2022-02-10 US US17/650,561 patent/US20230026909A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN111406054B (zh) | 2024-01-02 |
RU2020121391A (ru) | 2022-01-10 |
RU2020121391A3 (he) | 2022-01-20 |
CN111406054A (zh) | 2020-07-10 |
AU2018379321B2 (en) | 2024-05-16 |
US20200339569A1 (en) | 2020-10-29 |
CA3083061A1 (en) | 2019-06-13 |
AU2018379321A1 (en) | 2020-06-11 |
KR20200097294A (ko) | 2020-08-18 |
EP3720851A1 (en) | 2020-10-14 |
IL274973B1 (he) | 2024-03-01 |
JP7369458B2 (ja) | 2023-10-26 |
US20230026909A1 (en) | 2023-01-26 |
JP2021505684A (ja) | 2021-02-18 |
IL274973A (he) | 2020-07-30 |
WO2019110663A1 (en) | 2019-06-13 |
MX2020005841A (es) | 2020-09-07 |
BR112020010534A2 (pt) | 2020-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254756A1 (zh) | 作為組蛋白脫乙酰酶6抑制劑的1,3,4-噁二唑衍生物化合物及包含其的藥物組合物 | |
HK1251571A1 (zh) | 作為組蛋白脫乙酰基酶6抑制劑的1,3,4-噁二唑磺酰胺衍生化合物及含有其的醫藥組合物 | |
HK1251549A1 (zh) | 作為組蛋白去乙酰酶6抑制劑的1,3,4-噁二唑磺酰胺衍生物及含其的醫藥組合物 | |
HUE061967T2 (hu) | Hiszton deacetiláz-6 inhibitor oxadiazol-amin származékok és az azokat tartalmazó gyógyászati készítmény | |
HK1251939A1 (zh) | 作為組蛋白脫乙酰酶6抑制劑的1,3,4-噁二唑酰胺衍生物化合物及含有其的藥物組合物 | |
HRP20181534T1 (hr) | Novi spojevi kao inhibitori histonske deacetilaze 6 i farmaceutski pripravci koji ih sadrže | |
IL274973A (he) | תולדות 4,2,1-אוקסאדיאזול כמעכבי היסטון דהאצטילאז | |
DK3956324T3 (da) | 1,3,4-oxadiazol-derivater som histondeacetylase-inhibitorer | |
IL263360A (he) | שילובים המכילים מעכבי היסטון דיסיטילאזים | |
IL267899A (he) | נגזרות של 1,1,1-טריפלואורו-3-הידרוקסיפרופאנ-2-יל קרבמט כמעכבי magl | |
EP3129373A4 (en) | Histone deacetylase inhibitors | |
IL267465A (he) | מעכבי היסטון דיאצטילאז | |
IL256438B (he) | מעכבי היסטון דיאצטלאז | |
DK3297992T3 (da) | Heterocykliske alkylderivatforbindelser som selektive histondeacetylase-inhibitorer og farmaceutiske sammensætninger omfattende samme | |
EP3397617A4 (en) | INHIBITORS OF HISTONE DEM ETHYLASE | |
GB201803361D0 (en) | Histone deacetylase inhibitors | |
EP3436445A4 (en) | HISTONDEMETHYLASEINHIBITOREN | |
EP3430008A4 (en) | INHIBITORS OF HISTONE DEM ETHYLASE | |
EP3383494A4 (en) | Histone deacetylase INHIBITORS | |
EP3445752A4 (en) | INHIBITORS OF HISTONE DEM ETHYLASE |